Macular Degeneration News and Research

Latest Macular Degeneration News and Research

NIH to fund grants for epigenetic research

The National Institutes of Health announced today that it will fund 22 grants on genome-wide studies of how epigenetic changes -- chemical modifications to genes that result from diet, aging, stress, or environmental exposures -- define and contribute to specific human diseases and biological processes.

17 Sep 2009

Patient enrollment for Phase 3 clinical trials of VEGF Trap-Eye completed

Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) today announced the completion of patient enrollment in two randomized, double-masked, Phase 3 clinical trials evaluating VEGF Trap-Eye in the treatment of the neovascular form of age-related macular degeneration (wet AMD).

14 Sep 2009

Alcon to acquire ESBATech AG

Alcon (NYSE:ACL) announced today that it has entered into a definitive agreement to acquire ESBATech AG, a Swiss biotechnology company. Alcon will pay ESBATech shareholders $150 million in cash at closing, plus contingent payments of up to $439 million based upon the achievement of future research and development milestones that would be expected to create value for Alcon.

14 Sep 2009

BioTrends Research Group ranked by Philadelphia 100 for the second consecutive time

For the second year in a row, BioTrends Research Group, Inc. has been ranked as one of the fastest-growing, privately-held companies in the Philadelphia region by the Philadelphia 100, a joint project of the Wharton Small Business Development Center, the Entrepreneurs' Forum of Greater Philadelphia, and the Philadelphia Business Journal.

10 Sep 2009

SupportSight free seminar for people affected by macular degeneration

Chester County Eye Care Associates has joined with the Macula Vision Research Foundation (MVRF) to sponsor a SupportSight seminar in West Chester on September 26th.

9 Sep 2009

$NEI awards grant to Vivakor for developing a digital photo-refractor$

NEI awards grant to Vivakor for developing a digital photo-refractor

Vivakor, Inc. announced that the National Institutes of Health-National Eye Institute has awarded a grant to Vivakor, Inc. in Coralville, IA through the Small Business Innovation Research Awards.

4 Sep 2009

Chlorella green food sourced from algae contains a wide range of essential nutrients

"While we can still take advantage of summer's fresh produce, ensuring a consistent supply of whole foods throughout the year can reap benefits for those focused on aging as healthfully as possible," says Michael E. Rosenbaum, M.D. "Chlorella, a super green food sourced from a fresh water algae, contains the widest range of essential nutrients available in any single food source, including potassium, all B vitamins, magnesium, zinc, iron and 18 vital amino acids." Though beneficial for all life stages, Sun Chlorella can especially help aging adults thanks to these health rewards.

1 Sep 2009

Alimera Sciences' $5 million extension of Series C financing closed

Alimera Sciences, Inc., today announced that it has closed a $5 million extension of its Series C financing which was originally completed in March 2008.

28 Aug 2009

University of Southern California's gerontology students participate in an interactive senior sensitivity training program

Gerontology students at University of Southern California had an opportunity to "become senior citizens" on Friday thanks to Trading Ages(TM), an interactive senior sensitivity training program sponsored by SCAN Health Plan.

24 Aug 2009

New molecule blocks lymphangiogenesis

Researchers in the laboratory of Dr. Jayakrishna Ambati at the University of Kentucky have discovered the first naturally occurring molecule that selectively blocks lymphatic vessel growth. In an article in the Aug. 9, 2009 online edition of Nature Medicine, they report the identification of a new molecule known as soluble VEGFR-2 that blocks lymphangiogenesis - the growth of lymphatics - but not blood vessel growth.

11 Aug 2009

Stemcells, Inc. reports Q2 financials

Results for the quarter reflect the Company’s acquisition of the operations of Stem Cell Sciences Plc (SCS), a UK-based company focused on cell-based technologies for drug discovery and screening.

10 Aug 2009

Aptamers offer unique therapeutic advantages

A novel class of drugs composed of single strands of DNA or RNA, called aptamers, can bind protein targets with a high strength and specificity and are currently in clinical development as treatments for a broad range of common diseases, as described in a comprehensive review article published online ahead of print in Oligonucleotides.

5 Aug 2009

Anti-growth factor drugs raise hope and concern for treatment of children's eye diseases

A new class of antibody drugs may provide a powerful new tool for the treatment of eye diseases in children, but specialists need to be alert for the possibility of serious side effects, according to an editorial in the August Journal of AAPOS (American Association for Pediatric Ophthalmology and Strabismus), published by Elsevier.

3 Aug 2009

Omega-3 fatty acids may protect against progression of age-related macular degeneration

Omega-3 fatty acids found in fatty fish such as tuna and salmon may protect against progression of age-related macular degeneration (AMD), but the benefits appear to depend on the stage of disease and whether certain supplements are taken, report researchers at the Laboratory for Nutrition and Vision Research (LNVR), Jean Mayer USDA Human Nutrition Research Center on Aging (HNRCA) at Tufts University.

18 Jun 2009

New antioxidant supplement may help slow sight loss in elderly

Queen's University Belfast academics have helped develop an antioxidant supplement which may slow down sight loss in elderly people.

18 Jun 2009

Discovery of key molecular target in age-related macular degeneration

A team of researchers led by Dr. Jayakrishna Ambati at the University of Kentucky has discovered a biological marker for neovascular age-related macular degeneration (AMD), the leading cause of blindness in older adults.

15 Jun 2009

A new way to tackle age-related macular degeneration

Researchers at the University of North Carolina at Chapel Hill School of Medicine in collaboration with lead investigators at the University of Kentucky have identified a new target for the diagnosis and treatment of age-related macular degeneration, the most common cause of blindness in older Americans.

15 Jun 2009

People with Down syndrome may have more cancer-protective genes

Most cancers are rare in people with Down syndrome, whose overall cancer mortality is below 10 percent of that in the general population. Since they have an extra copy of chromosome 21, it's been proposed that people with Down syndrome may be getting an extra dose of one or more cancer-protective genes.

20 May 2009

Saffron could stop blindness and cure eye disease

Italian scientists say they have found that saffron may hold the key to stopping vision loss as people age and in treating some eye diseases.

17 May 2009

Diet rich in nuts and olive oil protects against age-related macular degeneration

New research has found that a diet which is low in trans fats and regularly includes nuts, olive oil and other foods containing omega-three fatty acids appears to offer some protection from the eye disease age-related macular degeneration (AMD).

13 May 2009